Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (1166)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
May 24, 2024 (publication date) through Nov 8, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Garcia JA, Alcaraz D, Holgado E, Couñago F. Pembrolizumab autoimmune related diabetes: Moving forward, keep learning. World J Clin Oncol 2024; 15(5): 576-579 [PMID: 38835848 DOI: 10.5306/wjco.v15.i5.576] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v15/i5/576.htm |
| Number | Citing Articles |
| 1 |
Mirac Burak Tak, Zaid Munir, Ahmet Aydin. Pembrolizumab-Induced Insulin-Dependent Diabetes Mellitus in a Patient With Triple-Negative Breast Cancer: A Rare Immune-Related Adverse Event. Cureus 2024; doi: 10.7759/cureus.73049
|